<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1975694886019755&amp;ev=PageView&amp;noscript=1">
friendly doctor and patient

Your Partner for Vaccine Clinical Trial Management

For over 30 years, Remington-Davis (RDI) has worked with pharmaceutical companies and CROs on complex vaccine drug studies. With a track record of successfully managing more than 600 clinical trials, organizations trust us to drive their vaccine innovations forward.

How we help vaccine clinical trials succeed

At Remington-Davis, we’re positioned to help with all aspects of vaccine clinical trials. From Phase I through Phase IV trials, we can offer support in:
  • Patient Recruitment
  • Patient Management
  • Data Collection
  • Regulatory Compliance

Patient Recruitment

Patient Recruitment

With an extensive pre-screened patient database and an exceptional 35% diversity rate, we’ve helped sponsors and CROs meet enrollment targets for vaccine trials—bringing creative recruitment strategies to the table to meet even the tightest of timelines. Once we identify participants who best align with study criteria, we engage and onboard them quickly to keep trials on schedule and within budget.

Patient Management

Patient Management

We strive to make patients feel valued and supported at every stage of your trial—and it shows. Regular communications with patients keep them informed and engaged, while minimizing their wait times during site visits. Flexible scheduling, free transportation services, and at-home delivery options further support our 98% patient retention rate.

Data Collection

Data Collection

Information gathered from patients during a vaccine trial is entered into our electronic data capture system the same day for real-time visibility, with any discrepancies automatically flagged. For trials that allow for more flexibility, our team has extensive experience in decentralized methodologies—and we’ve even helped pivot trials to this model.

Regulatory Compliance

Regulatory Compliance

From initiation to close-out, we employ proactive strategies to keep vaccine trials compliant. Our team closely monitors trial operations and data quality at every stage to ensure timely submissions, proper progress reporting, and adherence to Good Clinical Practice standards.

Highlights from our extensive vaccine trial experience

E. Coli Vaccine in Adults with Chronic UTI 

  • Phase II placebo-controlled trial
  • 66 randomized patients

Norovirus Vaccine in Healthy Adults

  • Phase III placebo-controlled trial
  • Screened 86 patients; randomized 83 

Botulism Vaccine for Production of Botulism Immunoglobin

  • Partnered with defense contractor
  • 3 studies with total enrollment of 57 subjects

Staphylococcus Aureus Vaccine in Adults Undergoing Elective Spinal Fusion 

  • Partnered with orthopedic center to enroll subjects 
  • Screened 49 patients; randomized 47 
  • Exceeded study goal of 25 participants

Clostridium Difficile Vaccine in Adults 50 and Older 

  • Partnered with community hospital 
  • Screened 45 patients; randomized 44
  • Exceeded study goal of 20 participants

Interested in participating in a study?

Discover the latest RDI studies that are currently enrolling, learn more about their focus, and find out how you can participate in groundbreaking research.

Trial management expertise in a patient-centric environment

At Remington-Davis, we’re committed to creating positive patient experiences. Our 7,500 square-foot facility in Columbus, Ohio is a reflection of that.

RDI’s modern facility features a home-like environment that includes Wi-Fi, beverages, food, and other comforts to support a positive experience. When appointments are long, meals are provided at no cost. When there are prolonged wait periods, we offer study participants a private space that’s complete with reclining chairs and other comforts.

Our goal is to make participants feel cared for from the moment they arrive at our site to the moment your trial is complete.

What industry professionals have to say about working with RDI

“If a company doing a performance study asks me for a recommended clinical trial site, RDI would be the first one I think about. They offer very good service in an ideal setting.” - Shoshana Friedman, VP of Clinical & Regulatory Affairs
Remington-Davis logo

Partner with us for your next vaccine trial.

At Remington-Davis Clinical Research, we are committed to supporting you with trusted clinical research services. Schedule a 30-minute consultation with us to discuss your clinical trial management challenges and learn how we can help.